Palomino Laboratories (PALX) Change in Accured Expenses (2023 - 2025)

Palomino Laboratories has disclosed Change in Accured Expenses across 3 years of filings, most recently posting $464910.0 for Q3 2025.

• Change in Accured Expenses for Q3 2025 came in at $464910.0, up 16486.16% year-over-year; the trailing twelve-month figure through Sep 2025 was $458934.0 (up 2413.74% YoY), and the FY2024 annual result was $5443.0, up 143.75% from the prior year.
• Change in Accured Expenses came in at $464910.0 for Q3 2025 at Palomino Laboratories, up from -$5035.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $464910.0 in Q3 2025 to a low of -$41256.0 in Q4 2024.
• The 3-year median for Change in Accured Expenses is -$177.5 (2024), against an average of $59648.9.
• Peak annual rise in Change in Accured Expenses reached 16486.16% in 2025, while the deepest fall reached 59.44% in 2025.
• Palomino Laboratories' Change in Accured Expenses stood at -$28442.0 in 2023, then slumped by 45.05% to -$41256.0 in 2024, then surged by 1226.89% to $464910.0 in 2025.
• The last three Change in Accured Expenses figures came in at $464910.0 (Q3 2025), -$5035.0 (Q2 2025), and $40315.0 (Q1 2025), per Business Quant data.